Biotech

All Articles

Bicara, Zenas seek IPOs to press late-phase resources towards market

.Bicara Therapeutics and also Zenas Biopharma have offered new motivation to the IPO market along wi...

Genentech to close cancer immunology research study division

.Genentech is going to close its own cancer cells immunology study department, as well as unit mind ...

Kezar falls strong lump but to verify its well worth in stage 1 test

.Kezar Lifestyle Sciences is actually falling its dim phase 1 sound growth medicine as the biotech g...

Acelyrin drops izokibep, dismisses 3rd of team

.Despite izokibep sustaining its newfound winning touch in the center, Acelyrin is no longer concent...

Rivus' stage 2 obesity-related heart failure test hits endpoint

.Rivus Pharmaceuticals has plumped up the customers of its fat-busting, muscle-sparing medicine pros...

Ovid stops preclinical work, IV program after soticlestat neglect

.Ovid Therapy presently uncovered last month that it was trimming back its own headcount as the comp...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Port

.Eli Lilly has actually opened a $700 million R&ampD center in the Boston ma Port, increasing its ow...

Boundless Biography produces 'reasonable' layoffs 5 months after $100M IPO

.Merely five months after securing a $100 thousand IPO, Boundless Bio is actually actually laying of...

Halda's $126M is going to accelerate 'secure and also eliminate' lump medications

.The first stages of oncology R&ampD aren't except appealing brand-new techniques, and Halda Therapi...

Lykos 'regrets' certainly not disclosing study transgressions along with author

.Psychopharmacology has actually drawn 3 posts regarding midstage clinical test records analyzing Ly...